90 related articles for article (PubMed ID: 1843714)
1. [Effects of adrenergic beta 2 agonists by oral route on theophylline blood levels].
Terra Filho M; Santos SR; Cukier A; Verrastro C; Carvalho-Pinto RM; Fiss E; Vargas FS
Rev Hosp Clin Fac Med Sao Paulo; 1991; 46(4):170-2. PubMed ID: 1843714
[TBL] [Abstract][Full Text] [Related]
2. [Influence of the combination of theophylline and beta 2 agonists by oral route on pulmonary function of patients with chronic obstructive lung disease].
Carvalho-Pinto RM; Terra Filho M; Cukier A; Santos SR; Verrastro C; Teixeira LR; Vargas FS
Rev Hosp Clin Fac Med Sao Paulo; 1991; 46(4):166-9. PubMed ID: 1843713
[TBL] [Abstract][Full Text] [Related]
3. Oral doxophylline in patients with chronic obstructive pulmonary disease.
Villani F; De Maria P; Ronchi E; Galimberti M
Int J Clin Pharmacol Ther; 1997 Mar; 35(3):107-11. PubMed ID: 9088999
[TBL] [Abstract][Full Text] [Related]
4. [The influence of serum theophylline concentration on the bronchodilating effect of salbutamol inhalation for bronchial asthma].
Tsukioka K; Nakamata M; Kondo A; Hashimoto T
Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Jul; 28(7):950-5. PubMed ID: 1977948
[TBL] [Abstract][Full Text] [Related]
5. [A single dose of theophylline in the evening in chronic obstructive airway disease. Serum concentration and lung function parameter].
Kaik G
Fortschr Med; 1984 Nov; 102(43):1120-2. PubMed ID: 6510864
[TBL] [Abstract][Full Text] [Related]
6. [Theophylline plus salbutamol in chronic bronchial obstruction. The additive effects of combination therapy in comparison with salbutamol monotherapy].
Bossert J; Träger E
Fortschr Med; 1989 Apr; 107(11):255-8. PubMed ID: 2659475
[TBL] [Abstract][Full Text] [Related]
7. Slow release theophylline in patients with airways obstruction with particular reference to the effects of food upon serum levels.
Thompson PJ; Kemp MW; McAllister WA; Turner-Warwick M
Br J Dis Chest; 1983 Jul; 77(3):293-8. PubMed ID: 6351891
[TBL] [Abstract][Full Text] [Related]
8. The combined effect of theophylline and terbutaline in patients with chronic obstructive airway diseases.
Lamont H; van der Straeten M; Pauwels R; Moerman E; Bogaert M
Eur J Respir Dis; 1982 Jan; 63(1):13-22. PubMed ID: 7040097
[TBL] [Abstract][Full Text] [Related]
9. Oral fenoterol versus sustained release theophylline in adult asthmatics.
Lucena MI; Almagro J; Andrade RJ; Hidalgo Sanchez R; Sanchez de la Cuesta F
Int J Clin Pharmacol Ther; 1997 Jan; 35(1):19-23. PubMed ID: 9021437
[TBL] [Abstract][Full Text] [Related]
10. [A comparative study of the pharmacokinetics of oral preparations of theophylline].
Tsoĭ AN; Gneushev ET; Maĭorova EM; Gavrilenko LN; Kunes VG
Farmakol Toksikol; 1990; 53(5):39-42. PubMed ID: 2253747
[TBL] [Abstract][Full Text] [Related]
11. Serum theophylline and ventilatory function in chronic obstructive lung disease. Comparison between two slow-release formulations of theophylline.
Tantucci C; Grassi V; Verdecchia P; Cornelli U; Sorbini CA
Int J Clin Pharmacol Ther Toxicol; 1985 Oct; 23(10):560-4. PubMed ID: 3905630
[TBL] [Abstract][Full Text] [Related]
12. The effects of inhaled albuterol and oral theophylline on gastroesophageal reflux in patients with gastroesophageal reflux disease and obstructive lung disease.
Ruzkowski CJ; Sanowski RA; Austin J; Rohwedder JJ; Waring JP
Arch Intern Med; 1992 Apr; 152(4):783-5. PubMed ID: 1558436
[TBL] [Abstract][Full Text] [Related]
13. Treatment of reversible chronic airways obstruction with doxofylline compared with slow-release theophylline: a double-blind, randomized, multicentre trial.
Melillo G; Balzano G; Jodice F; De Felice A; Campisi V; Capone M; Di Filippo A; Foddai G; Franzone JS; Grossi E
Int J Clin Pharmacol Res; 1989; 9(6):397-405. PubMed ID: 2699466
[TBL] [Abstract][Full Text] [Related]
14. Long-term therapy with sustained-release theophylline.
Myhre KI; Arnulf V; Walstad RA
Pharmatherapeutica; 1985; 4(2):92-7. PubMed ID: 3903782
[TBL] [Abstract][Full Text] [Related]
15. Serum theophylline concentrations and pulmonary function tests after administration of two sustained-release formulations containing theophylline in patients affected by chronic obstructive lung disease.
Fontana G; Cresci F; Lo Sapio P; Panuccio P
Int J Clin Pharmacol Res; 1987; 7(5):351-6. PubMed ID: 3667008
[TBL] [Abstract][Full Text] [Related]
16. [Measurement of blood theophylline levels in the child: will this affect methods of prescription? (author's transl)].
de Blic J; Scheinmann P; Menillet G; Santais MC; Ruff F; Paupe J
Nouv Presse Med; 1979 Apr; 8(16):1311-4. PubMed ID: 482098
[TBL] [Abstract][Full Text] [Related]
17. The use of parenteral aminophylline in patients taking slow release theophylline preparations: an observation of clinical practice.
Arbab OA; Wiggins J; Ayres JG; Stableforth DE
Br J Dis Chest; 1985 Apr; 79(2):161-71. PubMed ID: 3986120
[TBL] [Abstract][Full Text] [Related]
18. Post-mortem concentrations of salbutamol, terbutaline and theophylline in asthma patients.
Lindsjö M; Boman G; Lindström B; Strandberg K; Wiholm BE
Eur J Respir Dis; 1987 Jul; 71(1):2-9. PubMed ID: 3653302
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic comparison of a once-daily and twice-daily theophylline delivery system.
González MA; Kisicki J; Straughn AB
Clin Ther; 1994; 16(4):686-92. PubMed ID: 7982257
[TBL] [Abstract][Full Text] [Related]
20. [Therapy of obstructive respiratory tract diseases with pure theophylline retard].
Arens PJ
Med Klin Prax; 1982 Aug; 77(18):48-53, 67. PubMed ID: 6752679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
